Advanced in Chronic B-Cell Leukemia (CBCL)

Dr. Daniel Lebovic

Hematology | Oncology
Corewell Health
Great Lakes Cancer Management Specialists
19229 Mack Avenue, Suite 24, 
Grosse Pointe Woods, MI 
On Staff At
Accepting New Patients
Offers Telehealth
24 Years of Experience
Advanced in Chronic B-Cell Leukemia (CBCL)
Corewell Health
Great Lakes Cancer Management Specialists
19229 Mack Avenue, Suite 24, 
Grosse Pointe Woods, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Lebovic is a Hematologist and an Oncologist in Grosse Pointe Woods, Michigan. Dr. Lebovic has been practicing medicine for over 24 years and is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma, Polycythemia Vera, Bone Marrow Aspiration, and Endoscopy. Dr. Lebovic is currently accepting new patients.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Chronic B-Cell Leukemia (CBCL).

Graduate Institution
University Of Toronto Faculty Of Medicine, 2002
Residency
Albert Einstein College of Medicine of Yeshiva University
Specialties
Hematology
Oncology
Licenses
Internal Medicine in MI
Board Certifications
American Board Of Internal Medicine
American Board Of Internal Medicine
Fellowships
University of Michigan Health System
Hospital Affiliations
Corewell Health Beaumont Grosse Pointe Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Great Lakes Cancer Management Specialists
19229 Mack Avenue, Suite 24, Grosse Pointe Woods, MI 48236
Call: 313-884-5522
Other Locations
Great Lakes Cancer Management Specialists
11885 East 12 Mile Road, Suite 100A, Warren, MI 48093
Call: 586-576-1615

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q
A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q
Enrollment Status: Completed
Publish Date: September 09, 2025
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2025
Intervention Type: Drug, Other
Study Drugs: Brentuximab vedotin, Rituximab, Lenalidomide
Study Phase: Phase 3
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
A Phase 3 Open-Label, Randomized Study of LOXO-305 Versus Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Pirtobrutinib, Idelalisib, Bendamustine, Rituximab
Study Phase: Phase 3
View 2 Less Clinical Trials

18 Total Publications

Real world evaluation of Evusheld in prevention of COVID-19 in immunocompromised patients: An observational cohort study.
Real world evaluation of Evusheld in prevention of COVID-19 in immunocompromised patients: An observational cohort study.
Journal: The American journal of the medical sciences
Published: July 18, 2025
View All 18 Publications
Similar Doctors
Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Sami N. Malek
Hematology | Oncology
Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Sami N. Malek
Hematology | Oncology

Regents Of The University Of Michigan

1500 E Medical Ctr, Suite 0331, 
Ann Arbor, MI 
 (43.0 miles away)
734-936-5738
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

Sami Malek is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Malek is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Follicular Lymphoma, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Malek is currently accepting new patients.

Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Mark S. Kaminski
Oncology | Hematology
Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Mark S. Kaminski
Oncology | Hematology
1500 E Medical Center Dr, 
Ann Arbor, MI 
 (42.8 miles away)
734-936-4000
Languages Spoken:
English
See accepted insurances

Mark Kaminski is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Kaminski is rated as an Elite provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Gastric Lymphoma, and Bone Marrow Aspiration.

Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Yasmin Karimi
Hematology | Hematology Oncology | Oncology
Distinguished in Chronic B-Cell Leukemia (CBCL)
Dr. Yasmin Karimi
Hematology | Hematology Oncology | Oncology

Regents Of The University Of Michigan

1500 E Medical Ctr Dr, 
Ann Arbor, MI 
 (42.8 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Yasmin Karimi is a Hematologist and a Hematologist Oncology provider in Ann Arbor, Michigan. Dr. Karimi is rated as a Distinguished provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Bone Marrow Aspiration.

VIEW MORE CHRONIC B-CELL LEUKEMIA (CBCL) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lebovic's expertise for a condition
ConditionClose
    • Distinguished
    • Anemia
      Dr. Lebovic is
      Distinguished
      . Learn about Anemia.
      See more Anemia experts
    • Chronic Myelogenous Leukemia (CML)
      Dr. Lebovic is
      Distinguished
      . Learn about Chronic Myelogenous Leukemia (CML).
      See more Chronic Myelogenous Leukemia (CML) experts
    • Monoclonal Gammopathy of Undetermined Significance (MGUS)
      Dr. Lebovic is
      Distinguished
      . Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).
      See more Monoclonal Gammopathy of Undetermined Significance (MGUS) experts
    • Multiple Myeloma
      Dr. Lebovic is
      Distinguished
      . Learn about Multiple Myeloma.
      See more Multiple Myeloma experts
    • Philadelphia-Negative Chronic Myeloid Leukemia
      Dr. Lebovic is
      Distinguished
      . Learn about Philadelphia-Negative Chronic Myeloid Leukemia.
      See more Philadelphia-Negative Chronic Myeloid Leukemia experts
    • Polycythemia Vera
      Dr. Lebovic is
      Distinguished
      . Learn about Polycythemia Vera.
      See more Polycythemia Vera experts
    View All 9 Distinguished Conditions
    • Advanced
    • Adult Immune Thrombocytopenia
      Dr. Lebovic is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Aleukemic Leukemia Cutis (ALC)
      Dr. Lebovic is
      Advanced
      . Learn about Aleukemic Leukemia Cutis (ALC).
      See more Aleukemic Leukemia Cutis (ALC) experts
    • Appendix Cancer
      Dr. Lebovic is
      Advanced
      . Learn about Appendix Cancer.
      See more Appendix Cancer experts
    • Ataxia-Pancytopenia Syndrome
      Dr. Lebovic is
      Advanced
      . Learn about Ataxia-Pancytopenia Syndrome.
      See more Ataxia-Pancytopenia Syndrome experts
    • Autoimmune Hemolytic Anemia
      Dr. Lebovic is
      Advanced
      . Learn about Autoimmune Hemolytic Anemia.
      See more Autoimmune Hemolytic Anemia experts
    • Breast Cancer
      Dr. Lebovic is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    View All 37 Advanced Conditions
    • Experienced
    • Acute Eosinophilic Pneumonia
      Dr. Lebovic is
      Experienced
      . Learn about Acute Eosinophilic Pneumonia.
      See more Acute Eosinophilic Pneumonia experts
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Lebovic is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Monoblastic Leukemia (AmoL)
      Dr. Lebovic is
      Experienced
      . Learn about Acute Monoblastic Leukemia (AmoL).
      See more Acute Monoblastic Leukemia (AmoL) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Lebovic is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Lebovic is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Lebovic is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    View All 111 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Close
        0 / 1000

        Please provide us with the below insurance information:

                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.